CSIMarket
 


West Pharmaceutical Services Inc   (WST)
Other Ticker:  
 


West Pharmaceutical Services Inc's ROI from its second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is West Pharmaceutical Services Inc's ROI in the second quarter of 2024?
West Pharmaceutical Services Inc achieved a return on average invested assets (ROI) of 17.8 % in its second quarter of 2024, this is above WST's average return on investment of 15.56%.
West Pharmaceutical Services Inc s investments during the 12 months ending in the second quarter of 2024 are valued at $2 billion

ROI decreased relative to the period ending Mar 31 2024, due to the decline in net income.

Within the Healthcare sector 18 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2024 from 43 to 163.

Definition and Formula of Return on Investment


Return On Investment (Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
Y / Y Investment Change TTM -0.82 % 4.58 % 10.81 % 13.64 % 12.94 %
Y / Y Net Income Change TTM 1.2 % 3.01 % 43.99 % 80.98 % 175.17 %
Investment (TTM) in Millions 2,757 2,859 3,061 3,122 3,055
Return On Investment (TTM) 17.8 % 18.81 % 19.26 % 18.26 % 17.44 %
WST's Overall Ranking # 163 # 43 # 323 # 389 # 458
Seq. Investment Change TTM -2.46 % -1.83 % 0.57 % 2.99 % 2.85 %
Seq. Net Income Change TTM -7.7 % -4.16 % 6.08 % 7.85 % -6.05 %
Net Income (TTM) in Millions 525 569 593 559 519




Return On Investment WST's Ranking
Within: No.
Industry # 5
Sector # 19
Overall # 163

Return On Investment Statistics
High Average Low
26.42 %
15.56 %
7.37 %
(Dec 31 2021)   (March 31, 2016)







Financial Statements
West Pharmaceutical Services Inc's II. Quarter Investments $ 2,757 Millions WST's Balance sheet
West Pharmaceutical Services Inc's II. Quarter Income $ 111 Millions Quarterly WST's Income Statement
WST's Income by Division See WST's Income by Division


WST Annual Return On Investment (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Total Investments in Millions 3,061 2,991 2,652 2,220 1,937
Y / Y Investment Growth 2.34 % 12.77 % 19.47 % 14.57 % 14.29 %
Net Income in Millions 593 586 662 346 242
Y / Y Net Income Growth 1.28 % -11.47 % 91.16 % 43.24 % 16.82 %
Annual Return On Investment 19.39 % 19.59 % 24.96 % 15.6 % 12.48 %


Annual Roi Comment
In the fiscal year 2023 ROI deteriorated to 19.39 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
WST's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for WST's Competitors
Roi for West Pharmaceutical Services Inc's Suppliers
Return On Investment for WST's Customers

Other Ratios
WST's Roa WST's Inventory Turnover Ratio WST's Growth Rates WST's Dividend Statistics
WST's Profitability Ratios WST's Asset Turnover Ratio WST's Dividend Growth
WST's Roe WST's Valuation Ratios WST's Financial Strength Ratios WST's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector ROI
Protagonist Therapeutics inc   37.74 %
National Research Corporation  37.64 %
Mettler Toledo International Inc  36.92 %
Medpace Holdings Inc   36.84 %
Idexx Laboratories Inc  36.50 %
Quince Therapeutics Inc   33.71 %
Exelixis Inc   32.02 %
Johnson and Johnson  30.31 %
Lantheus Holdings Inc   28.19 %
Carlisle Companies Incorporated  25.58 %
Tg Therapeutics Inc   25.31 %
Iradimed Corporation  23.13 %
Corcept Therapeutics Inc  23.12 %
Cardiff Lexington Corporation  22.21 %
Semler Scientific inc   21.17 %
Cassava Sciences Inc  20.29 %
Chemed Corporation  20.22 %
Halozyme Therapeutics Inc   19.43 %
Eli Lilly And Company  19.05 %
Zoetis Inc   18.58 %
Merck and Co Inc   18.31 %
Insulet Corporation  18.09 %
United Therapeutics Corporation  17.70 %
Edwards Lifesciences Corporation  17.25 %
West Pharmaceutical Services Inc   17.23 %
Harmony Biosciences Holdings inc   16.93 %
Zura Bio Limited  16.75 %
Resmed Inc   16.23 %
Alpha Pro Tech Ltd   15.83 %
Tenet Healthcare Corp  15.04 %


Date modified: 2024-09-08T09:52:14+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com